Inhibition of Bacterial Gene Transcription with an RpoN-Based Stapled Peptide

Autor: Payne, Sterling R., Pau, Daniel I., Whiting, Amanda L., Kim, Ye Joon, Pharoah, Blaze M., Moi, Christina, Boddy, Christopher N., Bernal, Federico

Publikováno v: In Cell Chemical Biology 20 September 2018 25(9):1059-1066

Design, synthesis, and evaluation of transition-state analogs as inhibitors of the bacterial quorum sensing autoinducer synthase CepI

Autor: Higgins, Erin L., Kellner-Rogers, Julian S., Estanislau, Alexandra M., Esposito, Alec C., Vail, Nora R., Payne, Sterling R., Stockwell, Julia G., Ulrich, Scott M.

Publikováno v: In Bioorganic & Medicinal Chemistry Letters 1 May 2021 39

Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-Cλinterface

Autor: Bagert, John D., Oganesyan, Vaheh, Chiang, Chi-I, Iannotti, Mike, Lin, Jia, Yang, Chunning, Payne, Sterling, McMahon, Will, Edwards, Samuel, Dippel, Andrew, Hutchinson, Mark, Huang, Fengying, Aleti, Vineela, Niu, Chendi, Qian, Chen, Denham, Jessica, Ferreira, Sofia, Pradhan, Pallab, Penney, Mark, Wang, Chunlei, Liu, Wenhai, Walseng, Even, Mazor, Yariv

Publikováno v: mAbs; December 2023, Vol. 15 Issue: 1

Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the C H 1-C λ interface.

Autor: Bagert JD; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Oganesyan V; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Chiang CI; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Iannotti M; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Lin J; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Yang C; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Payne S; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., McMahon W; Process and Analytical Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Edwards S; Process and Analytical Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA., Dippel A; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Hutchinson M; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Huang F; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Aleti V; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Niu C; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Qian C; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Denham J; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Ferreira S; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Pradhan P; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Penney M; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Wang C; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Liu W; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Walseng E; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA., Mazor Y; Biologics Engineering, AstraZeneca, Gaithersburg, MD, USA.

Publikováno v: MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2273449. Date of Electronic Publication: 2023 Nov 06.